Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2009) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacology and Therapeutics | journal | 4.101 Q1 | 233 | 102 | 339 | 20033 | 3632 | 338 | 9.95 | 196.40 |  |
| 2 | Drug Metabolism Reviews | journal | 1.450 Q1 | 108 | 26 | 113 | 4882 | 573 | 108 | 4.99 | 187.77 | |
| 3 | Recent Patents on CNS Drug Discovery | journal | 0.743 Q2 | 36 | 19 | 70 | 2426 | 195 | 70 | 2.89 | 127.68 |  |
| 4 | Expert Opinion on Emerging Drugs | journal | 0.863 Q2 | 54 | 45 | 134 | 5224 | 386 | 134 | 3.00 | 116.09 |  |
| 5 | Drug Resistance Updates | journal | 3.991 Q1 | 132 | 16 | 52 | 1836 | 571 | 52 | 12.58 | 114.75 | |
| 6 | Current Neuropharmacology | journal | 1.038 Q1 | 103 | 35 | 81 | 3841 | 197 | 79 | 2.09 | 109.74 | |
| 7 | Current Signal Transduction Therapy | journal | 0.168 Q3 | 22 | 22 | 47 | 2387 | 18 | 47 | 0.38 | 108.50 | |
| 8 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 27 | 55 | 2785 | 42 | 55 | 0.76 | 103.15 | | |
| 9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.954 Q1 | 52 | 27 | 72 | 2740 | 246 | 72 | 3.07 | 101.48 | |
| 10 | Expert Review of Neurotherapeutics | journal | 0.775 Q2 | 98 | 147 | 519 | 13586 | 1289 | 466 | 2.49 | 92.42 | |
| 11 | Neurotherapeutics | journal | 2.326 Q1 | 136 | 75 | 198 | 6608 | 1175 | 183 | 6.28 | 88.11 |  |
| 12 | Expert Review of Clinical Pharmacology | journal | 0.151 Q3 | 60 | 58 | 71 | 5034 | 32 | 61 | 0.45 | 86.79 | |
| 13 | Current Topics in Pharmacology | journal | 0.118 Q4 | 8 | 15 | 52 | 1247 | 7 | 52 | 0.15 | 83.13 |  |
| 14 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 21 | 74 | 1744 | 152 | 74 | 2.07 | 83.05 | | |
| 15 | Open Access Journal of Clinical Trials | journal | 15 | 4 | 0 | 332 | 0 | 0 | 0.00 | 83.00 |  | |
| 16 | Expert Opinion on Drug Safety | journal | 0.779 Q2 | 90 | 68 | 240 | 5545 | 673 | 192 | 2.84 | 81.54 | |
| 17 | CNS Drugs | journal | 1.217 Q1 | 129 | 86 | 250 | 6860 | 1085 | 221 | 4.47 | 79.77 | |
| 18 | BioDrugs | journal | 1.124 Q1 | 79 | 35 | 126 | 2782 | 442 | 117 | 4.24 | 79.49 | |
| 19 | Drugs | journal | 1.273 Q1 | 188 | 167 | 636 | 13257 | 2707 | 504 | 5.12 | 79.38 | |
| 20 | Journal of International Peacekeeping | journal | 0.101 Q4 | 14 | 15 | 44 | 1145 | 8 | 42 | 0.15 | 76.33 | |
| 21 | PPAR Research | journal | 0.952 Q1 | 59 | 39 | 169 | 2968 | 391 | 158 | 2.34 | 76.10 | |
| 22 | Cancer and Chemotherapy Reviews | journal | 0.120 Q4 | 4 | 20 | 34 | 1520 | 2 | 34 | 0.06 | 76.00 |  |
| 23 | Biologics: Targets and Therapy | journal | 0.131 Q3 | 47 | 49 | 137 | 3723 | 35 | 134 | 0.26 | 75.98 | |
| 24 | Expert Opinion on Pharmacotherapy | journal | 0.613 Q2 | 93 | 271 | 794 | 20462 | 1915 | 773 | 2.52 | 75.51 | |
| 25 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.589 Q2 | 30 | 28 | 78 | 2051 | 175 | 78 | 2.29 | 73.25 | |
| 26 | Expert Opinion on Investigational Drugs | journal | 1.251 Q1 | 117 | 165 | 481 | 12080 | 1956 | 449 | 4.54 | 73.21 | |
| 27 | Infection and Drug Resistance | journal | 65 | 6 | 0 | 435 | 0 | 0 | 0.00 | 72.50 | | |
| 28 | AIDS Reviews | journal | 1.445 Q1 | 62 | 22 | 79 | 1571 | 304 | 73 | 3.90 | 71.41 | |
| 29 | Perspectives in Medicinal Chemistry | journal | 0.103 Q4 | 17 | 3 | 7 | 212 | 0 | 7 | 0.00 | 70.67 | |
| 30 | Clinical Pharmacokinetics | journal | 1.494 Q1 | 184 | 60 | 212 | 4237 | 1153 | 202 | 5.36 | 70.62 | |
| 31 | Side Effects of Drugs Annual | book series | 0.100 Q4 | 9 | 53 | 103 | 3707 | 2 | 53 | 0.02 | 69.94 | |
| 32 | OncoTargets and Therapy | journal | 86 | 23 | 0 | 1608 | 0 | 0 | 0.00 | 69.91 | | |
| 33 | Open Neuropsychopharmacology Journal | journal | 6 | 12 | 0 | 838 | 0 | 0 | 0.00 | 69.83 | | |
| 34 | Expert Review of Anticancer Therapy | journal | 0.895 Q2 | 85 | 166 | 539 | 11461 | 1262 | 492 | 2.40 | 69.04 | |
| 35 | Targeted Oncology | journal | 0.347 Q2 | 59 | 31 | 96 | 2034 | 43 | 85 | 0.42 | 65.61 |  |
| 36 | Current Drug Therapy | journal | 0.209 Q3 | 20 | 27 | 50 | 1744 | 33 | 48 | 0.66 | 64.59 | |
| 37 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 28 | 75 | 1790 | 233 | 75 | 2.94 | 63.93 | | |
| 38 | Inflammopharmacology | journal | 0.478 Q2 | 68 | 32 | 132 | 2045 | 220 | 127 | 1.77 | 63.91 |  |
| 39 | Primary Care - Clinics in Office Practice | journal | 0.327 Q3 | 59 | 56 | 152 | 3579 | 171 | 139 | 1.28 | 63.91 | |
| 40 | Drugs of the Future | journal | 0.275 Q3 | 46 | 111 | 357 | 7063 | 245 | 356 | 0.59 | 63.63 | |
| 41 | Current Treatment Options in Oncology | journal | 0.947 Q1 | 66 | 26 | 124 | 1640 | 301 | 123 | 2.36 | 63.08 | |
| 42 | Drugs and Aging | journal | 0.749 Q2 | 109 | 90 | 248 | 5633 | 659 | 236 | 3.01 | 62.59 | |
| 43 | HIV Therapy | journal | 14 | 60 | 0 | 3725 | 0 | 0 | 0.00 | 62.08 | | |
| 44 | CNS Neuroscience and Therapeutics | journal | 0.839 Q2 | 91 | 35 | 31 | 2080 | 84 | 30 | 2.71 | 59.43 | |
| 45 | Drugs of Today | journal | 0.569 Q2 | 57 | 102 | 266 | 6046 | 529 | 261 | 1.99 | 59.27 | |
| 46 | Vascular Health and Risk Management | journal | 0.616 Q2 | 82 | 110 | 330 | 6458 | 704 | 325 | 2.07 | 58.71 | |
| 47 | Therapeutic Advances in Cardiovascular Disease | journal | 0.512 Q2 | 41 | 43 | 55 | 2499 | 97 | 49 | 1.76 | 58.12 | |
| 48 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.378 Q2 | 56 | 61 | 222 | 3529 | 289 | 220 | 1.23 | 57.85 | |
| 49 | Cochrane Database of Systematic Reviews | journal | 1.651 Q1 | 327 | 1327 | 2773 | 75812 | 12919 | 2772 | 4.01 | 57.13 | |
| 50 | Therapeutics and Clinical Risk Management | journal | 0.351 Q2 | 70 | 101 | 319 | 5725 | 436 | 307 | 1.41 | 56.68 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data